Avenue Therapeutics Inc. (ATXI) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Avenue Therapeutics Inc.

    NASDAQ: ATXI · Real-Time Price · USD
    0.69
    -0.06 (-8.00%)
    At close: Oct 02, 2025, 3:12 PM
    0.69
    0.00%
    After-hours: Oct 02, 2025, 03:12 PM EDT

    Avenue Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 n/a n/a n/a n/a
    Gross Profit
    		 n/a n/a n/a n/a
    Operating Income
    		 -11.28M -14.54M -8.04M -3.74M
    Interest Income
    		 -176K 126K 20K 7K
    Pretax Income
    		 -11.65M -10.49M -3.6M -3.73M
    Net Income
    		 -11.65M -10.38M -3.55M -3.73M
    Selling & General & Admin
    		 4.64M 4.18M 5.34M 2.48M
    Research & Development
    		 6.64M 10.36M 2.7M 1.25M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 11.28M 14.54M 8.04M 3.74M
    Interest Expense
    		 n/a n/a 1.16M n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 n/a 14.54M 8.04M 3.74M
    Income Tax Expense
    		 n/a n/a n/a -7K
    Shares Outstanding (Basic)
    		 12.95M 141K 29.14K 1.13M
    Shares Outstanding (Diluted)
    		 12.95M 141.22K 29.14K 1.13M
    EPS (Basic)
    		 -0.9 -73.6 -121.91 -3.29
    EPS (Diluted)
    		 -0.9 -73.48 -121.91 -3.29
    EBITDA
    		 -11.28M 4.05M -3.6M -3.73M
    EBIT
    		 n/a -10.49M -3.6M -3.73M
    Depreciation & Amortization
    		 n/a 14.54M 8.04M 3.74M

    Add to Watchlist